Podcasts about Alliance Group

Episode #148. The technical skill in this episode is brand purpose, providing marketers with the clarity on why their brand exists internally and externally, motivation for the whole organisation to get behind and creating a north star to focus on - whether that's strategic or tactical choices or how to bring this to life. Joining Abby is her guest Helen Jeremiah, Global Vice President for Croda, a company that makes specialised ingredients for beauty, personal care, and home care products. Having previously worked at Boots and Walgreen's Alliance Group, Helen is an experienced marketing leader who has worked across multiple disciplines including marketing, customer strategy, global marketing, global brand marketing, product development, insight and inclusivity. In this episode, Helen shares her definition of brand purpose and its significance beyond profit, authenticity, the importance of internal engagement, and agency partnerships to bring to life. Plus, her career highs and lows and advice for marketers of tomorrow. 00:00:00 Welcome and Introduction to Brand Purpose 00:03:03 Importance of Internal Engagement 00:04:48 Advice for Redefining Brand Purpose 00:07:08 Aligning Brand Purpose with Values 00:09:22 Multifaceted Nature of Brand Purpose 00:10:21 Stakeholder Engagement for Alignment 00:13:49 Measuring Brand Purpose Impact 00:16:43 Internal Perception of Brand Purpose 00:18:28 Helen's Personal Drive for Purpose 00:23:43 Agency Collaboration for Fresh Perspectives 00:25:49 Career Highs and Lows 00:31:51 Advice for Future Marketers Host: Abigail Dixon FCIM/ICF | LinkedInGuest: Helen Jeremiah | LinkedIn The Whole Marketer podcast is here to support and empower the people behind brands and businesses with the latest technical tools, soft and leadership skills and personal understanding for a fulfilling marketing career and life as a whole. For more info go to www.thewholemarketer.com

Episode #148. The technical skill in this episode is brand purpose, providing marketers with the clarity on why their brand exists internally and externally, motivation for the whole organisation to get behind and creating a north star to focus on - whether that's strategic or tactical choices or how to bring this to life.   Joining Abby is her guest Helen Jeremiah, Global Vice President for Croda, a company that makes specialised ingredients for beauty, personal care, and home care products. Having previously worked at Boots and Walgreen's Alliance Group, Helen is an experienced marketing leader who has worked across multiple disciplines including marketing, customer strategy, global marketing, global brand marketing, product development, insight and inclusivity.  In this episode, Helen shares her definition of brand purpose and its significance beyond profit, authenticity, the importance of internal engagement, and agency partnerships to bring to life.  Plus, her career highs and lows and advice for marketers of tomorrow.    00:00:00 Welcome and Introduction to Brand Purpose  00:03:03 Importance of Internal Engagement   00:04:48 Advice for Redefining Brand Purpose   00:07:08 Aligning Brand Purpose with Values   00:09:22 Multifaceted Nature of Brand Purpose   00:10:21 Stakeholder Engagement for Alignment   00:13:49 Measuring Brand Purpose Impact   00:16:43 Internal Perception of Brand Purpose   00:18:28 Helen's Personal Drive for Purpose   00:23:43 Agency Collaboration for Fresh Perspectives   00:25:49 Career Highs and Lows  00:31:51 Advice for Future Marketers    Host: Abigail Dixon FCIM/ICF | LinkedIn Guest: Helen Jeremiah | LinkedIn   The Whole Marketer podcast is here to support and empower the people behind brands and businesses with the latest technical tools, soft and leadership skills and personal understanding for a fulfilling marketing career and life as a whole. For more info go to www.thewholemarketer.com   

The New Zealand dollar is trading at a nearly two-year low, meaning New Zealanders can expect more pain at the petrol pumps. AA's fuel price spokesperson Terry Collins and Alliance Group's global sales director James McWilliam spoke to Paddy Gower.

 Is a Christchurch farm accountant who has written an excellent paper on the plight of the beleaguered meat processor - the Alliance Group - and the numbers don't stack up! See omnystudio.com/listener for privacy information.

New AI technology is giving farmers an insight into the eating quality of their lamb and beef. Alliance group-shareholders can now use Meat Eating Quality technology to analyse the tenderness, juiciness and flavour of meat. Chief executive Willie Wiese told Mike Hosking the tool predicts the performance of livestock using genetics. He says they've tested and validated the outcomes of the predictions against chemistry tests. Alliance will have regional benchmarking data on the new technology by the end of the year. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Fonterra chief executive Miles Hurrell says its Scope 3 emissions plan is a cost of doing business, with players across the co-op's value chain demanding emissions reductions. He tells Bryan that Fonterra is in a good place with a strong balance sheet and a streamlined strategy as it faces up to an uncertain global economic and geopolitical future.Federated Farmers has revealed some worrying statistics, with a large percentage of farmers having to look for off-farm income to bolster their balance sheets. Toby Williams says that sheep and beef farmers especially are doing it tough and many are having to put in extra hours to make ends meet.Senior reporter Neal Wallace takes a look at Alliance Group's search for new capital. He outlines the options on the table and the likelihood of farmers pitching in. Neal also has an update from Southland on the wet weather that's been hampering farmers.

Senior reporter Neal Wallace takes a look at Alliance Group's search for new capital. He outlines the options on the table and the likelihood of farmers pitching in.Neal also has an update from Southland on the wet weather that's been hampering farmers.

We ask the Chair of the Alliance Group if the meat-processing co-op has hit rock bottom and is rebounding after yesterday reporting a $95.8 million loss (on top of last year's $70.2 million loss). Plus we ask who, or what, is to blame for the dismal performance?   See omnystudio.com/listener for privacy information.

The meat processing sector is being encouraged to evolve to ensure it captures future demand. Alliance Group's confirmed Timaru's Smithfield meatworks will shut by the year's end due to declining sheep numbers – cutting up to 600 positions. BusinessDesk reports rival Silver Fern Farms wants to be constructively involved as Alliance works through a capital raise. Chief Executive Dan Boulton told Ryan Bridge he doesn't believe this downward trend will continue forever. “Our sheep, beef and venison farmers deserve to thrive, but to do that, they're going to need a really strong, efficient, and viable processing sector and that's going to require investment.” LISTEN ABOVESee omnystudio.com/listener for privacy information.

Currently, unemployment is sitting at 4.6 percent or 143,000 people out of work. Treasury forecast have it rising to 5.3 percent by this years end. Today, the Alliance Group confirmed it's shutting down it's meat processing plant in Timaru; that's 600 jobs gone. Earlier this month Winstone pulp closed two sites in the Ruapehu district with 230 losing their jobs and this week Kiwirail said it would offer all staff voluntary redundancy. How does that work and what do employees need to know if they've been offered redundancy? Money correspondent Susan Edmunds spoke to Lisa Owen.

Around 600 employees at Alliance Group's Timaru meatworks are out of a job, following an announcement that the co-op will close its Smithfield plant by the end of the year. Alliance revealed a proposal to shut the 139-year-old abbatoir two weeks ago because of a drop in sheep numbers, which was confirmed at an all-staff meeting this morning. Delphine Herbert reports from Timaru.

Tonight on The Panel, Mark Leishman and panellists Ed Amon and Claire Amos discuss the job losses to come with the closure of the Alliance Group's Smithfield plant in Timaru and students and staff of the University of Otago criticising the school's stance of 'institutional neutrality' regarding the Israeli-Palestinian conflict.

The confirmed closure of Alliance Group's processing plant looks to be New Zealand's loss and Australia's gain. The vast majority of the meatworks' 600 staff will be made redundant and Australian recruiters have captured the opportunity to poach workers. Managing Director of Australian Meatworks Recruiting and Training Organisation Wayne Herrod tells Heather du Plessis Allan the company would like to take between 50 to 200 people over the ditch. LISTEN ABOVESee omnystudio.com/listener for privacy information.

A blow to South Canterbury as Timaru's Smithfield meat-works is confirmed to be closing. The entire nearly 140-year-old site will close by December's end. Alliance Group's told staff they'll be offered re-deployment at its other processing plants, where possible. Waimakariri MP Matt Doocey told John MacDonald that he's gutted. He says it'll impact many families and be felt by the wider community. Christchurch Central MP Duncan Webb says it will have a knock-on effect for the city. He says the loss of 500 jobs means 500-less incomes being spent, which local businesses will feel. LISTEN ABOVE See omnystudio.com/listener for privacy information.

There's growing concerns about the future of small town New Zealand - with one expert warning 'tough conversations' are needed. The closure of Winstone Pulp International's Ruapehu mills have cost the region 230 jobs, and the proposed shutdown of Alliance Group's Smithfield meat processing plant in Timaru could cost over 600 more. Regional Development Minister Shane Jones says the need to achieve certain climate goals is driving down key industries - and negatively impacting regional New Zealand. "If we're not going to maintain access to gas and coal during a managed transition and we're going to continually make it more difficult for farmers to sustain production, we are going to see a contraction of the economy around some of our small towns." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Labour's Ag Spokesperson reflects on a bad day for her local electorate with the announcement of the mothballing of the Alliance Group's Smithfield plant in Timaru, with the loss of over 600 jobs. See omnystudio.com/listener for privacy information.

There's growing concerns about the future of small town New Zealand - with one expert warning 'tough conversations' are needed. The closure of Winstone Pulp International's Ruapehu mills have cost the region 230 jobs, and the proposed shutdown of Alliance Group's Smithfield meat processing plant in Timaru could cost over 600 more. Regional Development Minister Shane Jones says the need to achieve certain climate goals is driving down key industries - and negatively impacting regional New Zealand. "If we're not going to maintain access to gas and coal during a managed transition and we're going to continually make it more difficult for farmers to sustain production, we are going to see a contraction of the economy around some of our small towns." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Alliance Group is proposing a closure to its Timaru meat processing plant. Consultations are ongoing and will likely lead to the loss of 600 jobs. Minister for Regional Development Shane Jones joins Tim Beveridge on The Weekend Collective to discuss further. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Provincial New Zealand is hurting.   Alliance Group last week confirmed plans to close its Timaru meat processing plant in Smithfield, with the loss of hundreds of jobs.  It comes after earlier this month that Winstone Pulp International said will close two mills near Ohakune, which will see 230 people lose their jobs.   To discuss the impact facing small towns in New Zealand, and if there's a way out from them, today on The Front Page, we are joined by Dr Sean Connelly, senior lecturer at the school of geography at the University of Otago.  Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts. You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network. Host: Susie NordqvistSound Engineer: Dan GoodwinProducer: Ethan SillsSee omnystudio.com/listener for privacy information.

600 jobs are almost certainly gone from Timaru after workers were told by Alliance Group today it intends to close Smithfield meat processing plant. It's a body blow for the South Canterbury community with more than one percent of all of the Timaru district employed at the plant. Workers have been told it is just a proposal at this stage and there may be opportunities at Alliance's other sites around the country. But, as Timothy Brown reports, workers think the last nail is already in the coffin.

Up to 600 jobs are to go from the Alliance Group's meat processing plant in Timaru, with very little prospect of any workers being re-deployed to other plants. It's planning to wind down sheep meat, calf and venison processing at the Smithfield plant by the end of the year, a move that will carve vital jobs out of Timaru. Alliance said the proposed closure is due to a decline in sheep processing numbers caused by a change in land use, Alliance Group Chair Mark Wynne spoke to Lisa Owen.

The Alliance Group says a drop in our livestock numbers is behind a proposal shut a Timaru meatworks. It's called an all-staff meeting today to announce a proposal to close its Smithfield freezing works. It would stop sheep meat, calf, and night shift venison processing after this season, and remaining venison at the end of the year, at the latest. Group chair Mark Wynne told Heather du Plessis-Allan there's been a change in how farmers are using their land. He says the fundamental reason is declining livestock and in particular sheep - and the flow on effect that is has on the processing industry. LISTEN ABOVESee omnystudio.com/listener for privacy information.

The Alliance Group chairman on the mothballing of the Smithfield plant, with the loss of more than 600 jobs for the South Canterbury region.See omnystudio.com/listener for privacy information.

Employees of the Alliance Group's Smithfield meatworks in Timaru are worried they could lose their jobs in a restructure or full closure of the plant. Meatworkers Union national secretary Daryl Carran spoke to Corin Dann.

Staff at the Alliance Group's Smithfield meatworks in Timaru are anxiously awaiting an all-staff meeting today. Timaru District Council Mayor Nigel Bowen spoke to Ingrid Hipkiss.

It's a sad day for Timaru, with hundreds of meatwork jobs potentially on the line. Alliance Group has called everyone at its Smithfield meatworks to an all-staff meeting at 11am. Locals fear the plant will be mothballed this season, with production being moved to Invercargill, and up to 1200 people left out of work. Nathan Guy from the Meat Industry Association told Mike Hosking any job losses will be most unfortunate. But he says meat companies are very agile and make changes as they see fit, and today is about making the right decision for the company's future. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Sheep farmers are doing it tough right now, with farmgate returns dropping back after a few good years and input costs rising. Add to that the march of pine trees across the land, and there's talk of an existential crisis. Bryan asked AgriHQ senior analyst Mel Croad to give him the lay of the land and asked her what the sector needed to do to find prosperity again.Federated Farmers is calling on the government to tell councils to pause work on freshwater reforms. Otago Feds member Luke Kane says with signals pointing to changes in water regulations, it makes sense for regional councils to hit the brakes.Reporter Neal Wallace checks in from London, where he's spent time with the Alliance Group's UK team. They've hired a chef to come up with new recipes for those consumers who don't want the traditional lamb roast and learns that a football stadium is a key part of the strategy.

Reporter Neal Wallace checks in from London, where he's spent time with the Alliance Group's UK team. They've hired a chef to come up with new recipes for those consumers who don't want the traditional lamb roast and learns that a football stadium is a key part of the strategy.

If the values of your organization are not matching up with your personal values, this episode is for you!  In this conversation with the Austin Alliance Group team, we're tossing you the key to the golden handcuffs you're wearing at work as we explore the challenges and opportunities in creating a positive work culture. AAG has made it their mission to inspire workplaces to be more human. Fueled by the power of curiosity, vulnerability, and trust to create positive change in organizations, they know from experience, emphasizes the role of effective communication and feedback in building strong relationships between managers and employees. We discuss the importance of empathy, vulnerability, and trust in the workplace and the crucial need for leaders to take responsibility and lead by example.  Connect with the Austin Alliance Group Team: Website: www.austinalliancegroup.com  LinkedIn:  https://www.linkedin.com/company/austin-alliance-group  Timestamps: 00:00 Introduction to the Team from Austin Alliance Group 02:41 Changing the Mentality of HR 04:53 Challenging the Traditional Top-Down Approach 09:14 Evolving Leadership and Management Tactics 12:09 The Importance of Trust and Open Communication 16:50 Building Trust through Vulnerability 18:31 Authenticity in Creating a Positive Work Culture 23:11 Introduction and Discussion on Work Culture 24:40 Leadership's Role in Fostering a Healthy Work Environment 27:05 The Importance of Trust and Vulnerability in Building Strong Relationships 29:06 HR's Role in Shaping Company Culture 32:36 Navigating Difficult Work Situations: Prioritizing Well-being and Growth

The Chair of the Alliance Group comments on the response from the farmer meetings about controversial capital-raising programme, and he admits the world's largest sheep meat processor has not been well managed in the past 10 years. But has the board and management been incompetent or, worse, negligent? See omnystudio.com/listener for privacy information.

The Alliance Group chief executive says if farmers want to retain a 100% farmer-owned cooperative, then they must support the capital raising programme which was floated to shareholders last Friday. See omnystudio.com/listener for privacy information.

Is a Southland sheep and beef farmer (and 25 years ago was the 1999 Young Farmer of the Year). Today we get his take, as a large-scale supplier/shareholder, on the controversial Alliance Group capital-raising programme.  See omnystudio.com/listener for privacy information.

Imposter syndrome is a very real phenomenon that many individuals encounter so what do you do about it? Irene Sim, founder of the Coaching Alliance Group joins us to share her story where at the young age of 10 she encountered her first experience with having to speak up to the power that could change her and her family's life, then a second time when she migrated to Australia and didn't feel like she belonged. Always struggling with this pit and ickiness in her stomach and then she realized her power when remembering the courage of her 10-year-old self.  She shares with us how we marinate in social expectations and tend to internalize and make these messages our realities. But we don't have to. During our conversation, she graciously shares her 4 step method of overcoming. 1) Call it out, 2) Lean into the ABCD process 3) Marvel at what happens and then celebrate it 4) Let your inner champion rise to the call. You have to listen to the full episode to really capture her ABCD method and I highly encourage it. Practical and informative, a gift that she shares beautifully. Her next mission is to put full attention on the systems we have and by creating her Allies in Leadership Network we can use privilege to make great changes. Irene spent many years as a Senior Executive Service of Australia Treasury and Taxation Office, now turned Executive Coach supporting others of all stages on their journey to break free from societal biases, set their own terms and thrive as authentic and powerful leaders. If you want to know you show up as a leader, visit us at www.wilempowered.com to take our free leadership quiz, and learn things about yourself that you might not have been aware of. #Impostersyndrome  #leadership #exerciseyourvoice #power #wilempowered #wiltalk

En nuestro programa de hoy, tenemos como invitado especial a Mario Romero, Gerente General de Alliance Group, para hablarnos sobre cómo presentar tu declaración de impuestos de la manera más inteligente, despejar dudas y mucho más. _________________________________________ Agenda hoy tu planificación financiera personal en el siguiente enlace: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://share.hsforms.com/1k82_Nn3RQey1VHuNgS8Grwc5s5b⁠

It's been a big few days for Southland steak producer Alliance Group - which last week had its Pure South 55 Day Aged Beef voted the BEST ribeye steak in the entire world at the World Steak Challenge in London. The beef category director at Alliance Group, Darren Drury joins us...

Former chairman of Beef + Lamb NZ, and former National Chief Government Whip, comments on the Alliance Group result, its procurement model and terms of trade and what to do with Winston Peters.See omnystudio.com/listener for privacy information.

The chief executive of the Alliance Group, the world's largest sheep meat exporter, comments on the co-operative's announcement yesterday of a loss before tax of $97.9 million for the year ending September 30, 2023 (FY2022 profit of $116.3m) on a turnover of $2.0 billion (FY2022 $2.2b). We also talk about a flawed procurement model and tough terms of trade for paying suppliers.See omnystudio.com/listener for privacy information.

Alliance Group this week announced a significant loss for the 2023 financial year. The co-operative lost over $70 million, as geo-political tensions, inflationary pressures and weakening global markets continued to affect the red meat sector. The Country's Jamie Mackay says the current volatile market has created extra pressure for the struggling sector. LISTEN ABOVESee omnystudio.com/listener for privacy information.

How do you transition from working in the corporate to finally starting and leading your own business?While it's not entirely impossible—I know a lot of people who took a leap of faith and started their own entrepreneurial journey—it takes a special kind of courage, especially for women and women of color to transition from the corporate setting to leading their own companies.So really, how do you do this?For Lesa Adeboye, CEO of Alliance Group, it's a matter of presenting your authentic self and building genuine relationships. With her mantra of “where there's a will, there's a way,” Lesa reminds us that it's not about being good at everything, but it's about knowing how to make real partnerships and identify the best people to engage when opportunities arise.In this episode, Lesa and I talk about her knowledge of govcon and how the desire for freedom motivated her to start her successful business after over 20 years in corporate. Thriving Points:I wasn't fearful about anything. But I made a lot of mistakes. Coming out of corporate, I thought I knew everything, so I had to learn that business is a whole other beast. I had to humble myself, but that took some time. I made a lot of mistakes but I learned a lot from the mistakes that I've made. - Lesa AdeboyeWhat I have learned—and it's taken a while—is bringing my authentic self to the table and making genuine relationships, doing business with the people that my personality resonates with. - Lesa AdeboyeI love women-owned businesses because I see it as an avenue to freedom. Entrepreneurship is an avenue to freedom. - Lesa AdeboyeGet to Know the Guest:Lesa Adeboye, the CEO of Alliance Group, has over 25 years of federal government contracting experience. Alliance Group's corporate capabilities include management consulting, professional and administrative services, and visual communications (film, animation, and graphic design). Before becoming a business owner, Lesa served in roles that include Director of Contracts and Procurement, Director of Business Development, and Executive Program Director, for Fortune 500, mid-sized, and small businesses.Connect with Lesa Adeboye:WebsiteLinkedInInstagramOther resources mentioned:The Four Agreements: A Practical Guide to Personal Freedom (A Toltec Wisdom Book) by Don Miguel Ruiz About the Show:Women Thriving in Business features candid unscripted conversations with entrepreneurs, business experts, authors, and academics aimed at contributing to business success. This weekly show provides interviews with business leaders who have built, grown, and are thriving in business. Nikki A. Rogers, host of the show, also discusses achievements, lessons learned, and advice for aspiring business owners to develop the mindset, strategies, and connections necessary to thrive in business. Whether you are just starting or you have been in business for decades, WTiB offers inspiration, strategies, and resources to help you THRIVE in business.Connect with Nikki:LinkedInInstagramYoutubeA Team Dklutr Production

Guest Steve Carr, Alliance Group, joins to discuss woke businesses. Why are businesses pandering to such a minority group? Can consumer take a stand a fight back? Discussion of ESG, croney capitalism, and out of touch corporate owners.  Hispanic Republicans push back against Democrats and corruption in DC. Do Democrats actually understand their constituents?  Republicans pass bill to restrain power in Executive branch. 

Age is a main factor when determining cancer care. In this ASCO Education podcast we speak to one of the top leaders in treatment for older patients who has also credited mentorship as a foundation for his career. Dr. Hyman Muss describes his childhood in Brooklyn, serving as a general physician for troops in Vietnam (6:18), the doctor who influenced his choice of hematology and oncology (7:48) and creating one of the first geriatric oncology fellowships in in the country (21:58).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Hyman Muss: None More Podcasts with Oncology Leaders  Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1) Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1) If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Pat Loehrer: Welcome to Oncology, Etc., an ASCO Education Podcast. I'm Pat Loehrer, director of Global Oncology and Health Equity at Indiana University.  Dave Johnson: And I'm Dave Johnson of Medical Oncology at the University of Texas Southwestern in Dallas, Texas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of our podcast is to introduce listeners to interesting and inspirational people and topics in and outside the world of Oncology. We have an inspirational guest today. Pat?  Pat Loehrer: If you ask anyone who's achieved any level of success and how they've achieved it, most likely they'll mention a number of people who've influenced them along the way. Quite often, these people reflect on their mentors, and after a certain time of accomplishment and reflection, they begin to mentor others. This is very much what our next guest has done. Dr. Hyman Muss has been a mentor to me and to Dave, and he's one of the most outstanding, wonderful people in the world, and we're so excited to have him today.   Dr. Hyman Muss served in the US Army in Vietnam, where he was awarded the Bronze Star Medal. He's an experienced Clinician Scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest in education and research is focused on cancer and older patients, and he is internationally recognized in this area. He's been the co-chair of the Alliance Committee on Cancer and Older Adults and won the BJ Kennedy Award from ASCO in Geriatric Care. His particular interest in research expertise is in the care of breast cancer patients, with a focus on the management of women who are of older ages. He's had a major interest in breast cancer survivorship and long-term toxicity of treatment and also served as the co-chair of the Breast Committee for the Alliance Group. He serves as a mentor for medical students, medical residents, junior faculty, and more recently, his Geriatric Oncology fellows. He served on the Board of Directors of the ASCO Foundation and on the ABIM, the American Board of Internal Medicine, where both Dave and I were privileged to work with him and witness his leadership and his deep breadth of knowledge.  Dr. Muss, thanks for joining us today. Dr. Hyman Muss: What a pleasure to be here. Thank you so much for inviting me. My mother would have loved the introduction.  Pat Loehrer: Well, speaking of that, tell us a little bit. You grew up in Brooklyn, so tell us a little bit about your parents. Your father was a dentist, I think, and your uncle was a general practitioner. So give us a little bit of the early life of Hy Muss. Dr. Hyman Muss: So I grew up in Brooklyn, New York. I was born and bred there. I went to Brooklyn Technical High School. I almost went to Brooklyn College, but I came back and went to Downstate Medical Center, which was just terrific. My tuition was $600 a year, but that's another story. My parents lived in the same neighborhood. My dad was a dentist, so we knew all the people. My uncle was the GP. You came into their office, sat down, and they saw you anytime, day or night, almost 24/7, something we're probably not going back to, but they had a profound influence on me. My uncle, as a GP, used to take me on house calls in Brooklyn when they were done, and he had an old Buick with MD plates. And I would go into these families, and they loved him, and they would give me ice cream and things. Maybe that's what made me a doctor. But it was a terrific and indelible experience. I had terrific parents. In those days, doctors and medical people usually lived in the same neighborhoods as their patients, so they really knew their people well. It was a terrific upbringing. I got to love medicine and have never had a look back. Dave Johnson: So your inspiration for a career in medicine obviously started at home. Tell us more about your formal education. You mentioned your high school education. What about college? And shortly thereafter?  Dr. Hyman Muss: Yeah, well, I went to Lafayette College. I was not the best high school student, but I had good college board scores or whatever they called them then. And I went to Lafayette and I thought I was going to be a chemist, a chemistry major. But I took enough premed courses and I spent a summer in a lab building cyclic ketones. And everybody was outside sitting on the lawn of the campus. And I was in there with all these distillation apparatus, and I said, “I don't think I can do this the rest of my life.” So I applied to medical school, and I got into several medical schools. But my father at that time was dying of metastatic bladder cancer. He had been a heavy smoker, and he was still working as a dentist. He worked until the day he unfortunately died. But I got into Downstate. We lived in Brooklyn, and my uncle, the GP, said, "Hy, you need to come home and help take care of your dad." I'm an only child, so I did. And I had a wonderful experience at Downstate.   Several years ago, I was listening to NPR and heard that one of my professors had won the Nobel Prize. Dr. Furchgott in physiology, one would have never thought. And I had a wonderful education and subsequently got into what was then Peter Bent Brigham in Boston, did my internship and residency there, joined the army and medical school, so I wasn't drafted, it was a program then. And then after first year of residency, I went to Vietnam, worked with an artillery battalion, a mystical experience, but no regrets. And then subsequently came back and did hematology and oncology at Brigham and at what was then the Jimmy Fund and Sidney Farber Cancer Center. And Tom Frei had just come. And I did hematology with a guy named Bill Moloney in Boston at Harvard. I'll tell you, a wonderful man. He was like a surrogate father. My dad had died by then, and I just feel I've had every opportunity to have a wonderful education and terrific mentors along the way. Dave Johnson: So we want to ask you about both of those gentlemen, but I would like to just, if I may, drop back to your experience in Vietnam. What was that like?  Dr. Hyman Muss: Well, I was 27 years old and I was put as the doctor for 500 men in artillery. My job was to take care of the general health of the troops. Fortunately, we didn't have many casualties. It wasn't a front war like my uncle, who was a GP actually in World War II, landed in Normandy about a week later and went all through World War II as a doctor. But Vietnam was an unusual war, there wasn't really a front. So my experience was I would go out to fire bases, which were units of about 100 men in the jungle, go out three days in a week in a helicopter, do sick call, check people. I dealt with really alcohol problems, unfortunately, a lot of drug problems. You had young people with really not a lot to do during the day, nothing much to do, and no real goal of being there. I did that for a while, and actually, the reason I got the Bronze Star was because I set up– It was nothing like standing in front of a machine gun. I'm not that kind of brave guy, but I set up a drug amnesty program so I got a lot of support from our regular field people to do this, so we didn't have to keep sending kids home with dishonorable discharges. And I learned a lot. I think we were reasonably successful. I learned a lot about artillery. I think overall it was a great experience in my life. Dave Johnson: Tell us how your interest in hematology and oncology originated. Where did that come from?  Dr. Hyman Muss: When I was an intern at the Brigham, Dr. Moloney was a very famous Harvard professor. He had studied war casualties after Hiroshima, he was one of the people that found the Philadelphia chromosome in CML. He was a guy that rounded on every single one of his leukemia patients every day. So I was an intern. So in those days I would go and see all the hematology people rounding because all the acute leukemia patients and all the serious cancer patients were right on the floors, right on the wards. We had 17-bed wards, and then we had some private rooms. And he loved what he did. And before I left for Vietnam, we didn't have Ara C and daunomycin. So every leukemia patient I saw died. This is '68 to '70. Yet we tried all these different regimens. Occasionally you got someone who did well for six months, a year. But his bedside manner was absolutely wonderful to me. He knew all the patients. He'd ask them about where they lived in Boston. His humanism was terrific, and yet I loved the diseases he treated. The stakes were high. We didn't have good treatment, and I decided that that's probably what I want to do.   So when I was in Vietnam, I applied and got back in the Hematology Fellowship and came back and did that. I saw Ara C and daunomycin. I gave the chemotherapy to them, and he'd say, "Go up and treat Harry Smith with Ara C and daunomycin." I had the syringes in my pocket, guys. Forget about hoods and mixing. And I'd go up and treat them and the marrow would be gone within four or five days. I did a bone marrow. They published their regimen in the New England Journal called COD, C-O-D because they also gave vincristine. So it was cytarabine, vincristine, and daunomycin, the COD regimen. It fit Boston. And I saw it was like the emergence of cisplatin after Larry Einhorn. You saw people that never survived going into remission and I saw some remissions in AML and it cemented it.  About my second year of residency, we had a child. I was running out of money. I was being paid $6,000 a year and I had the GI Bill. I went into Dr. Moloney and he talked with Dr. Franny Moore, who was head of surgery at the Brigham, and they made me the Sidney Farber Research Fellow, doubled my salary and I had to go to the Jimmy Fund and see cancer patients. And it so happened that was when Tom Frei came to Dana-Farber. And so I started rounding with Dr. Frei and seeing those patients. And I think the first day I walked in, I knew I wanted to do more than just leukemia because I saw groups of patients with every disease. We treated everybody with CMFEP, it didn't matter what cancer they had. And I just loved it and said, "My God, there's so much we can learn. What a great career." And so that got me into the oncology portion.   And then I was offered to stay at Harvard. They were going to make me an assistant professor, but they wanted me to do lab work. And I knew my personality, it just wasn't for me. I worked with a lovely guy named Frank Bunn, one of the world's great hem guys in his lab, and he's still a close friend in his 80s. And he told me one day, he said, "Hy, I don't think the lab is for you." And he actually helped me get my first job at Wake Forest University, which turned out to be wonderful. So that's how I ended up with my circuitous in HemOnc. And it's really from great mentors, it's from Bill Moloney, it's from Tom Frei, Dave Rosenthal, tons of wonderful people along the way that not only taught me a lot, but they seemed to love what they do, which is a gift in life to love what you do and love the people you're doing it with. They instilled that in me. Pat Loehrer: From there you went to Wake Forest and there's a couple of colleagues down there, I believe, that inspired you, Charlie Spurr and Bill Hazzard, who was the founding founder of geriatrics. Tell us about that experience and how'd that shape your life.  Dr. Hyman Muss: I was looking for a clinical job and I looked at Rochester, and I got snowed in one night in Wake Forest, and I said, “Where's the contract?” And I signed it. And my mother, who was living in New York City, didn't know where North Carolina was. My mother was from a family, was born over a candy store in Greenwich Village, and said, “Where are you going?” And then I showed her where it was, and she says, “They're going to kill you down there.” And it turned out to be one of the best decisions of my life. My wife Loretta, who both of you know so well, we got out of our VW with our dog and our daughter when we moved here, and VW bug, by the way, not a van, and she cried. It turned out it was one of the best opportunities.  Charlie Spurr was an iconic oncology leader. He actually did some of the early work on nitrogen mustard in Chicago during the war, the first chemotherapy drug. He was a terrific leader. He had patients programmed in on those IBM punch cards. He had little cards for the protocols, CMFEP, CMF, AC on little laminated index cards. I learned so much from him, and he was to me, great leaders and great mentors morph from things they do themselves to teaching other people, and whose brains have the ability of having the same dopamine shot when you see one of your fellows or young faculty present a wonderful study as you do. And your brain isn't saying, “I wish I was up there.” It's saying, “Isn't this so cool that this young man or woman or fellow or medical student is doing such a wonderful job?” And I had something to do with providing the soil for this seed to grow. That's the kind of guy he was. And so it was wonderful there.  And as I moved on, we got a new Chief of Medicine, Bill Hazzard. And I still hear from Bill on rare occasions, but Bill was one of the first geriatricians in the United States. He wrote the textbook, and his wish was that all the faculty and all the specialties get involved in a geriatric project. And so I had all those little index cards, and I looked and saw how many older people with metastatic breast cancer we'd given chemotherapy to. And these were little protocols, nothing like the protocols today, no 50-page consent forms, 50 pages of where your data is stored. They were like, here's the treatment, here's the dose mods. And I looked at those 70 patients with one of our residents, Kathy Christman, she may be retired now, but in any event, we wrote a paper and showed the old people did as well as the young with breast cancer. And we published it in JAMA. And it's one of the few papers in my career, I got no reviewers. They accepted the paper. I got no reviewers. So because I'm from Brooklyn, and my English is not what it should be, I had my friends read it to just make sure I didn't say anything egregious. But it got published and the next thing I know, my friends in medical oncology in the state were calling me. They said, “I got a 75-year-old woman here.” I'm saying, “Guys, I just wrote this paper. I really don't know anything about older people.” But slowly, with Bill Hazzard and others, I got more and more interested. I started reading about Geriatrics and I ended up making it a focal point of my career. It was kind of happenstance. And Bill was a wonderful mentor.  And then as I subsequently moved on, I worked with terrific people like Harvey Cohen, Lodovico Balducci, and Martine Extermann, all of them heavily involved with ASCO over the years as well, and B.J. Kennedy. They were wonderful to work with. And BJ was inspirational because BJ would get up at an ASCO meeting and he'd say when he saw the age cut off, he'd say, “How come you didn't let old people on that study? There'd be 1000 people in the audience.” And so he really was a great mentor. And I had the bittersweet opportunity of writing his obit for JCO years ago and kept up with his family a few years, but he was a wonderful man. Dave Johnson: I'm just reflecting on the fact that today, patient registries are sort of mainstream, but certainly in the ‘70s, ‘80s, even into the ‘90s, having a list of patients with a particular disorder seemed almost novel in many respects. And to have that was a godsend.  Dr. Hyman Muss: It was a godsend. I still remember those little file cards. And he called it the Oncology Research Center and it was a godsend. And you've got to remember, this is like ‘74, ‘75, it's a long time ago. Dave Johnson: So many of our listeners may not be as familiar with Wake Forest as they are with Duke and North Carolina, the other medical schools located there. But you were at right at a point where I mean, it was one of the top oncology programs in the country at that time. Still is, I don't mean to diminish it, but there was a who's who of people there at the time. And you were also involved in creating, I think, one of the first cooperative groups of sorts. It was the Piedmont Oncology Group. Tell us about that.  Dr. Hyman Muss: Oh, yeah, well, that brings back memories. So the NCI at that time wanted to get more, I think, rural and other smaller places involved in research. And they put out an RFA to form like regional cooperative groups. And we formed the Piedmont Oncology Association, the POA. We actually did well for a few years. We wrote some really good studies. We got one or two New England Journal articles. I worked with all the people, mainly in the community, community docs who would go on, and put people on the protocol. I mean, I looked at all the X-rays and scans in a lot of these patients myself as part of the studies we did. And it turned out to be a wonderful organization and it's still run today by Bayard Powell, who is one of our terrific fellows who's the head of Oncology at Wake Forest.  But after a while, we just couldn't compete with CALGB, of which I was a member of also, and ECOG and SWOG, even North Central Group, which was kind of formed in a similar venue, eventually merged. So we did a wonderful job for a while but the truth is we just didn't have the manpower to write studies for every disease site. So eventually we kind of petered out as a clinical trials group. But it's been maintained for educational programs and it's really served as a good resource for a lot of good education for the community oncologists who give most of the care in this country in the state. So it's been good. I think Pat kind of exceeded us with HOG, the Hoosier Oncology Group, which was in a similar vein. But it was a great experience and it was all Dr. Spurr, who thought of doing this and built it.  Dave Johnson: Certainly, it was inspirational in many people in and outside of Wake Forest. So with such an idyllic life, what in the world possessed you to move north to Vermont?  Dr. Hyman Muss: Well, you get this urgent life. You want to be a leader, you want to be a chief. Now, I tell younger people, if they love what they do, don't do it. So I got a wonderful opportunity at the University of Vermont to go up there and be Head of HemOnc. Chief of Medicine was a terrific guy, Burt Sobel. The university at that time, at one time it had a wonderful Oncology program. It had a federally funded cancer center with Irwin Krakoff and Jerry Yates, two other iconic guys. I don't know what the politics were but it had lost a tremendous amount of faculty, especially its clinical faculty, and they needed to rebuild it. And I went up and I thought, “Well, I'm in my 50s. This is going to be a great opportunity. If I don't do it now, I may never get the chance.” So I went up there and actually, it was a great opportunity. We hired terrific people. We got CALGB and we participated. We had actually a very good accrual for a small place and we had a very small but very effective cancer center. So it turned out to be a really good experience.  I worked with wonderful people. I recruited some wonderful people. But over time, the issues of the business of medicine, all the issues that happened, I'm saying I'm kind of losing my focus on clinical care and clinical trials, which I love to do. I don't need to tell either of you. I mean, Dave, you've been chief and department chair and Pat has run cancer centers. After a while, the administrative tasks just were so overwhelming and I didn't enjoy them, that I said, “I've got to get back in some type of more clinical focus.” And that's when I decided to look around and fortunately found what's turned out to be a dream job at UNC.  But it was a time of life. Maybe my ego got in the way of my logic. I don't regret it. I met and I think we rebuilt a wonderful clinical program. But you realize some of the resources of big places with-  we never had the research infrastructure to hire a lot of people and get big programs going on and great translational programs, just didn't have the funding. But it was great, and I have no regrets. And I learned how to tolerate the cold weather. And I have a lovely daughter, Sarah, who still lives up there. So we get back occasionally. And I've kept up with a lot of the people there. There are some wonderful people at UVM.  Pat Loehrer: From there, though, you were pulled down to North Carolina, where you've, again, built an incredible breast program there is outstanding. But you've created a Geriatric Oncology program, one of the first geriatric fellowships in oncology in the country. So tell us a little bit about that and what you feel may be your legacy is there at North Carolina.  Dr. Hyman Muss: Well, I had the opportunity over the years when I was at Wake, really, I got to know Shelley Earp, who's our cancer center director. I think maybe you were close to him, Pat. The longest surviving cancer center director on the planet, or among them. And we were good friends. And North Carolina's legislature actually gave the University of North Carolina substantial funding to improve cancer care in North Carolina, not just research. And so I had talked with Shelley about maybe moving, and because of the generosity of the state, really, he was able to really get me going, start a Geriatric Oncology program. And what I wanted to do was develop trials. As Dave says, I built a registry in 2009 here for older cancer patients using geriatric assessment. I have 2000 patients, which has been a resource for all types of faculty and fellows, and students to write papers. But I was able, with the support, to do things like this right from the get-go. And plus, I joined probably one of the best breast groups on the planet with Lisa Carey and Chuck Perou, and Larry, terrific people, Claire Dees. I had great luck in doing this, so I was able to really focus, get great support from my colleagues to build studies focusing on older people.  And then I had the great fortune of meeting Ned Sharpless, our prior NCI director. And Ned is one of the world's great aging biologists. And I don't mean aging as an adjective, he's really been a master on why we age, the biology of aging, cell senescence. So Ned taught me all about cell senescence and the mechanisms, especially the gene expression p16, which is like our own CDK inhibitor. And so I was able to start using his lab, collect samples, treat people with chemotherapy, follow them off with geriatric assessment. It was a great opportunity to do that here, and we got a lot of studies going and we showed what the pediatricians have known for years, that chemotherapy dramatically ages people, not just children, but adults. But it also allowed me to work with my colleagues in lymphoma and lung cancer to do little studies along the way.  And we eventually then built a T32 program. We got a T32, which we're kind of completing now our first five years to train oncology specialists in geriatrics. So the way we do it is they can be surgical oncologists, GU, we had a GYN oncologist, medical. With their HemOnc training, they do a year where they work with the geriatricians, so they go on geriatric inpatient service for a month and they really learn about older people. And part of it is a project. So we've been able to build that and develop a lot of programs with that. And I should say we've been very successful with mentorship and with ASCO support for things like YIAs, the late and great Arti Hurria, who absolutely an amazing woman. Some of her legacy at ASCO, the YIAs, and things. We've been successful in applying for some. So we've been able to build a whole spectrum of med and hematologists. We have an interest in Myeloma and AML focusing on older people. We've been able to build a whole team approach, including translational projects related to older people. And it's just been a great opportunity, and hopefully, my legacy here will be, too, and I'm working on it.  We have a wonderful guy, Bill Wood, who is very effective and has built this incredible coaching program to continue this legacy. Like many of us in this field, we are bothered because we all know the stats, we all know that first slide of the demographics of cancer, and yet it's been very hard in our culture to provide a lot of the services and build the clinical trials we need to best care for older people. It's still a major problem in this country. So as I cut back on my clinical care, I'm going to still advocate to try to improve the care of older people. Do geriatric assessment, build it into your clinical programs, get your hospitals to support you, convince them, build business plans, et cetera. And hopefully, that'll be my ultimate legacy, that we've made greater awareness of the older people, other than the usual stats, and we're really trying to care for them in a much more global sense, in a much more holistic sense than we've done. I hope we'll be successful. It's a slow haul, but we've got lots of great young people coming up through the pipelines, ASCO has been a great player in this. Many of you know people like Supriya Mohile and William Dale, Heidi Klepin, people, the next generation that's going to keep building this. So I hope the legacy will be that we get more buy-in, more interest, more trained people in other oncology-related subspecialties RadOnc, SurgOnc that will really focus on the care of older people. Dave Johnson: I don't think there's any doubt that that will be a part of your legacy Hy, but I think your legacy will be much broader than the world of geriatric oncology. Your mentorship leadership, your clinical skills, your educational capabilities, all of that will certainly last for many, many years in the future.  Well, I don't want to bring up a touchy topic, but you yourself are geriatric and we're wondering what your plans are for your semi-retirement. I recognize you're not retiring, but what do you like to do outside of medicine? Dr. Hyman Muss: I'll tell everybody who's interested in hearing this. On Tuesday, I had my 80th birthday.  Dave Johnson: Congratulations.  Dr. Hyman Muss: And I think I'm one of the most blessed guys. I'm pretty healthy. I married up -  my wife Loretta, who both of you, Pat Loehrer and Dave Johnson, know well.  Dave Johnson: Yeah, you definitely married up.  Dr. Hyman Muss: Yes. It's really carried me most of my life. She's great and so she flew up our three kids and we celebrated and I'm very fortunate. I have the enthusiasm and strength to do more clinical medicine. But I think the time has come for me to cut back my clinical medicine, so I'm going to do that in June. The hardest thing I've done is say goodbye to so many of my patients here.  We've been blessed. We have a lovely family. We're pretty close. I'm never bored, probably you two know well, I love to do things like fishing, outdoor stuff. I've really gotten into woodworking, so I'm not going to be bored. But there will be a small piece out of me when I walk out of that clinic in June. I know that and my two close psychiatry friends think it's going to really be a hard fall, but I don't think so. I still have some grants. In fact, I'm working with a fellow in City of Hope, Mina Sedrak, who's been very involved in ASCO, too. We are hoping to get an R01 looking at senolytic drugs that may prevent aging, and exercise in older women with breast cancer to see if we can reverse the trends of chemo. So my brain is still on that stuff, but the clinical care is going to be tough.  I had a note and for some reason, we talked about so many things. I wanted to mention that one of my great opportunities was joining the CALGB and then the Alliance and getting the support of Dr. Schilsky, Rich Schilsky, who's been one of the icons of ASCO to build cancer in the elderly working group with Dr. Harvey Cohen at Duke. And Harvey is one of the world's great geriatricians. And using that to get studies done, to incorporate studies with Arti Hurria on geriatric assessment, and really have it as a place where a lot of younger investigators could get started on a career in geriatric oncology. And that was really a great opportunity. It was kept on by Dr. Bertagnolli, who now is our NCI director, and I think was really the first group to really give good support for this. Dave Johnson: So we want to thank you very much for being our guest today.  We also want to thank our listeners of Oncology, Etc. This is an ASCO Educational Podcast where we talk about oncology medicine and much more. So if any of our listeners have an idea or a guest they would like for us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, visit ASCO's website at education.asco.org.   Thanks again for being our guest, Hy.  Dr. Hyman Muss: My pleasure. Thank you so much. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Welcome to another episode of the NASCAR Gambling Podcast on the Sports Gambling Podcast Network! Every Rod Villagomez and Cody Zeeb bring their love of NASCAR and their love of sports betting to you to help you set your bets for the weekend of NASCAR action. From the Craftsman Truck Series to the Xfinity Series, to the Cup Series, Rod and Cody have you covered. Today, Rod and Cody set up the NASCAR Xfinity Production Alliance Group 300 from the Auto Club Speedway in Fontana, California and give you some of their favorite bets. Which Stewart Haas race car driver will have the better race this week? What Cup Series regulars are making a start in the Xfinity series and can they come away with the win? How much will the Daytona hangover impact Austin Hill? Will JR Motorsports dominate in the warm California sun on Saturday? We'll answer these questions and more on this week's episode. Be sure to subscribe to the NASCAR Gambling Podcast on the SGPN App, and on Apple Podcasts or Spotify. Find Rod (@rjvillagomez) and Cody (@Husker_Zeeb) on Twitter. SGPN Merch Store - https://sg.pn/store Download The Free SGPN App - https://sgpn.app Check out SGPN.TV Support us by supporting our partners WynnBET - Bet $100 and get a $100! - https://sg.pn/WynnBET Underdog Fantasy code SGPN - 100% Deposit Match up to $100 - https://sg.pn/underdog Follow The Hosts On Social Media Rod Villagomez - http://www.twitter.com/rjvillagomez Cody Zeeb - http://www.twitter.com/Husker_Zeeb   Watch the Sports Gambling Podcast YouTube - https://www.sg.pn/YouTube Twitch - https://www.sg.pn/Twitch   Read & Discuss - Join the conversation Website - https://www.sportsgamblingpodcast.com Discord - https://sg.pn/discord Reddit - https://www.sg.pn/reddit Learn more about your ad choices. Visit podcastchoices.com/adchoices

Welcome to another episode of the NASCAR Gambling Podcast on the Sports Gambling Podcast Network! Every Rod Villagomez and Cody Zeeb bring their love of NASCAR and their love of sports betting to you to help you set your bets for the weekend of NASCAR action. From the Craftsman Truck Series to the Xfinity Series, to the Cup Series, Rod and Cody have you covered.Today, Rod and Cody set up the NASCAR Xfinity Production Alliance Group 300 from the Auto Club Speedway in Fontana, California and give you some of their favorite bets. Which Stewart Haas race car driver will have the better race this week? What Cup Series regulars are making a start in the Xfinity series and can they come away with the win? How much will the Daytona hangover impact Austin Hill? Will JR Motorsports dominate in the warm California sun on Saturday? We'll answer these questions and more on this week's episode.Be sure to subscribe to the NASCAR Gambling Podcast on the SGPN App, and on Apple Podcasts or Spotify. Find Rod (@rjvillagomez) and Cody (@Husker_Zeeb) on Twitter.SGPN Merch Store - https://sg.pn/storeDownload The Free SGPN App - https://sgpn.appCheck out SGPN.TVSupport us by supporting our partnersWynnBET - Bet $100 and get a $100! - https://sg.pn/WynnBETUnderdog Fantasy code SGPN - 100% Deposit Match up to $100 - https://sg.pn/underdogFollow The Hosts On Social MediaRod Villagomez - http://www.twitter.com/rjvillagomezCody Zeeb - http://www.twitter.com/Husker_Zeeb Watch the Sports Gambling PodcastYouTube - https://www.sg.pn/YouTubeTwitch - https://www.sg.pn/Twitch Read & Discuss - Join the conversationWebsite - https://www.sportsgamblingpodcast.comDiscord - https://sg.pn/discordReddit - https://www.sg.pn/reddit Learn more about your ad choices. Visit podcastchoices.com/adchoices

Welcome to another episode of the NASCAR Gambling Podcast on the Sports Gambling Podcast Network! Every Rod Villagomez and Cody Zeeb bring their love of NASCAR and their love of sports betting to you to help you set your bets for the weekend of NASCAR action. From the Craftsman Truck Series to the Xfinity Series, to the Cup Series, Rod and Cody have you covered. Today, Rod and Cody set up the NASCAR Xfinity Production Alliance Group 300 from the Auto Club Speedway in Fontana, California and give you some of their favorite bets. Which Stewart Haas race car driver will have the better race this week? What Cup Series regulars are making a start in the Xfinity series and can they come away with the win? How much will the Daytona hangover impact Austin Hill? Will JR Motorsports dominate in the warm California sun on Saturday? We'll answer these questions and more on this week's episode. Be sure to subscribe to the NASCAR Gambling Podcast on the SGPN App, and on Apple Podcasts or Spotify. Find Rod (@rjvillagomez) and Cody (@Husker_Zeeb) on Twitter. SGPN Merch Store - https://sg.pn/store Download The Free SGPN App - https://sgpn.app Check out SGPN.TV Support us by supporting our partners WynnBET - Bet $100 and get a $100! - https://sg.pn/WynnBET Underdog Fantasy code SGPN - 100% Deposit Match up to $100 - https://sg.pn/underdog Follow The Hosts On Social Media Rod Villagomez - http://www.twitter.com/rjvillagomez Cody Zeeb - http://www.twitter.com/Husker_Zeeb   Watch the Sports Gambling Podcast YouTube - https://www.sg.pn/YouTube Twitch - https://www.sg.pn/Twitch   Read & Discuss - Join the conversation Website - https://www.sportsgamblingpodcast.com Discord - https://sg.pn/discord Reddit - https://www.sg.pn/reddit Learn more about your ad choices. Visit podcastchoices.com/adchoices

See omnystudio.com/listener for privacy information.

"Market Leading Returns From Commercial Conversions"   In this Deals, Deals, Deals Podcast Series, we go Behind the Scenes on some of the UK's most Creative, Lucrative and Award-Winning Deals

The chair of the Alliance Group talks about a record annual result, a probable delay for this year's peak lamb kill, chief executive David Surveyor stepping aside in 2023, and a drought-breaker in Canterbury.See omnystudio.com/listener for privacy information.

Fadi has worked in the payment processing industry for more than 30 years. Fadi and his wife Kim formed Electronic Cash Systems (ECS) in September 1997, then the US Alliance Group, Inc. was formed in 2007 to offer multiple payment platforms across the US. Fadi and Kim founded the non-profit organization Aiden Whisper in October of 2017 as an avenue to give 100% of all donations raised to deserving causes.   Joining us on The Wow Factor this week is Fadi Cheikha, who talks all about how his childhood in Beiruit shaped his character as a persistent and creative leader passionate about helping those around him move forward in life. He shares the innovative way he got his first job in the finance industry and how it eventually led to him and his wife starting their own financial services company. Fadi and I also discuss his faith, how it manifests in his business, and why it led him and his wife to create a foundation that inspires people to give generously of both money and time.   “Generosity is not about money only. It's about time, and it's about giving and watering the seed that you have.” - Fadi Cheikha   “If you are dreaming big and sometimes that dream scares you, you're not dreaming big enough.” - Fadi Cheikha   “You learn from your past, you dream in the future, and you live in the moment.” - Fadi Cheikha   This Week on The Wow Factor: Why Fadi decided to come from Lebanon to the USA after his undergraduate degree Fadi's first job in a gas station and how he worked his way up to the general manager of 16 furniture stores by the age of 22 Why Fadi was prompted to move on from the furniture stores by the start of the first Iraq War When Kim, Fadi's wife, opened a company selling ATMs and how she persuaded Fadi to join her in building their own company What Fadi has found from a leadership standpoint that he looks back on as key drivers that helped their business grow The five fundamental principles that Fadi and USAG adhere to, including generosity Why Fadi believes that it's so hard for people to dream big, and why it's essential to grow into the realization of what God truly has in store for you How Aiden Whisper began and why he is so committed to helping others, allowing his employees the opportunity to serve, and living generously The importance of honesty, transparency, and forgiveness in the USAG company culture   Fadi Cheikha's Word of Wisdom: Know your gifts, live your life according to those gifts, and do not pretend to be somebody you are not.   Connect with Fadi Cheikha: US Alliance Group Website Aiden Whisper Website   Connect with The WOW Factor: The WOW Factor Website Connect with Brad Formsma via email Brad Formsma on LinkedIn Brad Formsma on Instagram Brad Formsma on Facebook Brad Formsma on Twitter  

Brian Meadows joins Randy to talk about the importance of trial and error in his career path, the value of being patience in business and in life, and how a painful personal loss inspires him to help others.  

Join your Juggernaut podcast hosts Stephenie Flood and Anthony James for a talk with Keith Myers, President of RE/MAX One & Alliance Group. Armed with a multi decades-long history in the industry, Keith shares his positive outlook on the market and some valuable life advice you will appreciate—especially those in the business, won't want to miss this one!